Lewy Body Dementia Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight

“Lewy Body Dementia Treatment Market”
Lewy Body Dementia Companies are Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition Therapeutics, Cephalon, Athira Pharma, Ortho-McNeil Neurologics, Inc., H. Lundbeck A/S, Axovant Sciences Ltd., GE Healthcare, Aptinyx, NeuroActiva, Inc., CuraSen Therapeutics, Inc., ACADIA Pharmaceuticals Inc., and others.

(Albany, USA) DelveInsight’s “Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The Lewy Body Dementia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Lewy Body Dementia market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Lewy Body Dementia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Lewy Body Dementia market.

 

To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market Forecast

 

Some of the key facts of the Lewy Body Dementia Market Report:

  • The Lewy Body Dementia market size was valued ~USD 670 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
  • In January 2025, C2N Diagnostics, LLC, a renowned organization recognized for its pioneering efforts in neurological diseases, is collaborating with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to explore the links between neurodegenerative disorders, including Alzheimer’s disease (AD) and neuronal α-synuclein diseases (NSD) such as Parkinson’s disease (PD), Lewy body dementia (LBD), and REM behavior disorder (RBD).
  • In January 2025, Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company focused on developing treatments for neurodegenerative disorders, announced that Dr. James E. Galvin, MD, MPH, will present topline findings from the ‘SHIMMER’ study on zervimesine (CT1812) for dementia with Lewy bodies at the International Lewy Body Dementia Conference (ILBDC). Dr. Galvin, the director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine, served as the study director and principal investigator for the SHIMMER study grant from the National Institute on Aging.
  • In December 2024, Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company focused on developing treatments for neurodegenerative diseases, reported topline findings from its exploratory Phase 2 ‘SHIMMER’ study. The results showed that CT1812 led to significant therapeutic improvements in behavioral, functional, cognitive, and motor functions in patients with dementia with Lewy bodies (DLB).
  • According to DelveInsight’s evaluation, there were a total of 21,401,659 prevalent cases of dementia in the 7MM, with 12,619,459 cases diagnosed in 2022.
  • In 2022, the total diagnosed prevalent cases of Dementia with Lewy Bodies (DLB) in the 7MM stood at 720,478, with expectations for an increase during the forecasted period from 2024 to 2034
  • In 2022, approximately 42% of the total diagnosed prevalent cases of Dementia with Lewy Bodies (DLB) in the 7MM were observed in the United States. These cases are anticipated to experience a substantial compound annual growth rate (CAGR) throughout the study period from 2020 to 2034.
  • In 2022, there were 161,541 males and 143,253 females diagnosed with DLB in the US. The prevalence of gender-specific cases of Dementia With Lewy Bodies is expected to rise during the forecast period.
  • Among European countries, the UK recorded the highest diagnosed prevalence of Dementia With Lewy Bodies with 47,275 cases in 2022, followed by Germany with 44,729 cases. Conversely, Spain had the lowest diagnosed prevalent cases of Dementia With Lewy Bodies..
  • Key Lewy Body Dementia Companies: Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition Therapeutics, Cephalon, Athira Pharma, Ortho-McNeil Neurologics, Inc., H. Lundbeck A/S, Axovant Sciences Ltd., GE Healthcare, Aptinyx, NeuroActiva, Inc., CuraSen Therapeutics, Inc., ACADIA Pharmaceuticals Inc., and others
  • Key Lewy Body Dementia Therapies: E2027, Neflamapimod, K0706, RVT-101, CT1812, K0706, Irsenontrine, Donepezil, ATH-1017, Galantamine, Memantine, Nelotanserin, DatSCAN, NYX-458, N-831(Traneurocin), CST-103, CST-107, Pimavanserin, and others
  • The Lewy Body Dementia epidemiology based on gender analyzed that through various secondary studies it can be found that LBD more commonly affects males than females
  • The Lewy Body Dementia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Lewy Body Dementia pipeline products will significantly revolutionize the Lewy Body Dementia market dynamics.

 

Lewy Body Dementia Overview

Lewy Body Dementia (LBD) is a progressive neurodegenerative disorder characterized by the abnormal buildup of protein deposits called Lewy bodies in the brain. These deposits disrupt normal brain function, leading to a combination of cognitive, motor, and behavioral symptoms. Lewy Body Dementia symptoms often include fluctuations in alertness, visual hallucinations, Parkinsonian motor symptoms (such as tremors, rigidity, and slow movement), and difficulties with attention and executive function.

Lewy Body Dementia diagnosis can be challenging due to symptom overlap with Alzheimer’s and Parkinson’s diseases. A comprehensive evaluation, including neurological exams, cognitive assessments, and brain imaging, is typically required for accurate diagnosis.

There are two main types: Dementia with Lewy bodies, where cognitive symptoms appear first, and Parkinson’s disease dementia, where motor symptoms precede dementia.

Although there is currently no cure, Lewy Body Dementia treatment focuses on managing symptoms. This may include medications for cognitive decline, mood disorders, and motor symptoms, as well as non-pharmacological interventions like physical therapy and cognitive support.

Lewy Body Dementia research is ongoing to better understand its causes and develop targeted therapies. Early recognition and a multidisciplinary care approach can significantly improve the quality of life for patients and caregivers.

 

Get a Free sample for the Lewy Body Dementia Market Report: https://www.delveinsight.com/report-store/lewy-body-dementia-market

 

Lewy Body Dementia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Lewy Body Dementia Epidemiology Segmentation:

The Lewy Body Dementia market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Lewy Body Dementia
  • Prevalent Cases of Lewy Body Dementia by severity
  • Gender-specific Prevalence of Lewy Body Dementia
  • Diagnosed Cases of Episodic and Chronic Lewy Body Dementia

 

Download the report to understand which factors are driving Lewy Body Dementia epidemiology trends @ Lewy Body Dementia Epidemiology Forecast

 

Lewy Body Dementia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Lewy Body Dementia market or expected to get launched during the study period. The analysis covers Lewy Body Dementia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Lewy Body Dementia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Lewy Body Dementia Therapies and Key Companies

  • E2027: Eisai
  • Neflamapimod: EIP Pharma
  • K0706: Sun Pharma
  • RVT-101: Axovant Sciences Ltd.
  • CT1812: Cognition Therapeutics
  • K0706: Cephalon
  • Irsenontrine: Eisai Inc.
  • Neflamapimod: EIP Pharma Inc
  • Donepezil: Eisai Co., Ltd.
  • ATH-1017: Athira Pharma
  • Galantamine: Ortho-McNeil Neurologics, Inc.
  • Memantine: H. Lundbeck A/S
  • Nelotanserin: Axovant Sciences Ltd.
  • DatSCAN: GE Healthcare
  • NYX-458: Aptinyx
  • N-831(Traneurocin): NeuroActiva, Inc.
  • CST-103, CST-107: CuraSen Therapeutics, Inc.
  • Pimavanserin: ACADIA Pharmaceuticals Inc.

 

Discover more about therapies set to grab major Lewy Body Dementia market share @ Lewy Body Dementia Treatment Market

 

Lewy Body Dementia Market Strengths

  • Increasing research and development to understand the diversity of the disease might improve the diagnosis of LBD thereby resulting in a lucrative market opportunity.
  • Current treatments are effective in relieving the symptoms and improving the quality of life of the patients.

 

Lewy Body Dementia Market Opportunities

  • Several organizations are actively working to provide information and increase awareness of such disorders.
  • There is only one approved treatment option for LBD which opens a platform of new therapies to boost the market ofLBD.
  • The pipeline for PMM is narrow as there is limited R&D activity

 

Scope of the Lewy Body Dementia Market Report

  • Study Period: 2020–2034
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Lewy Body Dementia Companies: Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition Therapeutics, Cephalon, Athira Pharma, Ortho-McNeil Neurologics, Inc., H. Lundbeck A/S, Axovant Sciences Ltd., GE Healthcare, Aptinyx, NeuroActiva, Inc., CuraSen Therapeutics, Inc., ACADIA Pharmaceuticals Inc., and others
  • Key Lewy Body Dementia Therapies: E2027, Neflamapimod, K0706, RVT-101, CT1812, K0706, Irsenontrine, Donepezil, ATH-1017, Galantamine, Memantine, Nelotanserin, DatSCAN, NYX-458, N-831(Traneurocin), CST-103, CST-107, Pimavanserin, and others
  • Lewy Body Dementia Therapeutic Assessment: Lewy Body Dementia current marketed and Lewy Body Dementia emerging therapies
  • Lewy Body Dementia Market Dynamics: Lewy Body Dementia market drivers and Lewy Body Dementia market barriers
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Lewy Body Dementia Unmet Needs, KOL’s views, Analyst’s views, Lewy Body Dementia Market Access and Reimbursement

 

To know more about Lewy Body Dementia companies working in the treatment market, visit @ Lewy Body Dementia Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Lewy Body Dementia Market Report Introduction

2. Executive Summary for Lewy Body Dementia

3. SWOT analysis of Lewy Body Dementia

4. Lewy Body Dementia Patient Share (%) Overview at a Glance

5. Lewy Body Dementia Market Overview at a Glance

6. Lewy Body Dementia Disease Background and Overview

7. Lewy Body Dementia Epidemiology and Patient Population

8. Country-Specific Patient Population of Lewy Body Dementia

9. Lewy Body Dementia Current Treatment and Medical Practices

10. Lewy Body Dementia Unmet Needs

11. Lewy Body Dementia Emerging Therapies

12. Lewy Body Dementia Market Outlook

13. Country-Wise Lewy Body Dementia Market Analysis (2020–2034)

14. Lewy Body Dementia Market Access and Reimbursement of Therapies

15. Lewy Body Dementia Market Drivers

16. Lewy Body Dementia Market Barriers

17. Lewy Body Dementia Appendix

18. Lewy Body Dementia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lewy Body Dementia Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight

Silicone Elastomers Market 2025 : Impressive Growth Ahead and Trends Forecast Strong Performance by 2029 | Expert Review

“Browse 359 market data Tables and 55 Figures spread through 295 Pages and in-depth TOC on “Silicone Elastomers Market””
The Silicone Elastomers market is witnessing robust growth driven by demand across automotive, electronics, and healthcare sectors. Key players like Dow, Wacker Chemie, Momentive, Elkem, and Shin-Etsu Chemical are leading innovations, expanding applications, and shaping market dynamics globally.

Silicone Elastomers Market size was USD 8.6 billion in 2024 to USD 12.3 billion by 2029, at a CAGR of 7.4% from 2024 to 2029. This research report provides a comprehensive analysis of the global industry, including market size, share, silicone elastomers market growth, demand, industry development status, and forecasts for the next few years. Silicone elastomers are used to enhance the performance of the products by extending their useful life, preserving their aesthetic appearance, and delivering performance and flexibility features. With ever increasing demands in the industry, silicone elastomers continue to evolve and become more innovative to meet these demands. The synthetic substance silicone, which has elasticity, heat resistance, and chemical stability, is used to make silicone elastomers, a kind of rubber. They are used in many industries because they perform and have more flexibility than conventional rubber.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6310524

“High temperature vulcanized segment is estimated to be the largest type in silicone elastomers market in 2024, in terms of value.”

High temperature vulcanized (HTV) silicone elastomers claim the leading position in the market due to their exceptional thermal stability and versatility. High temperature vulcanized silicone elastomers are favored for applications requiring prolonged exposure to elevated temperatures, making them crucial in industries such as automotive, aerospace, and industrial manufacturing. The demand for High temperature vulcanized silicone elastomers is propelled by their ability to maintain mechanical properties under extreme temperature conditions, ensuring durability and reliability in diverse end-use applications. Additionally, the material’s resistance to harsh environmental factors and its suitability for high-performance applications contribute to the dominance of HTV silicone elastomers in the market.

“Compression molding segment is estimated to be the fastest-growing process for silicone elastomers market during the forecast period 2024 to 2029.”

Compression molding emerges as the fastest-growing process in the silicone elastomers market due to its cost-effectiveness, scalability, and ability to produce large volumes with consistent quality. This method allows for efficient production of complex shapes and intricate designs, catering to the increasing demand for diverse silicone components in industries like automotive & transportation, healthcare, and consumer goods. The simplicity and shorter cycle times associated with compression molding contribute to its accelerated adoption, particularly in applications requiring precision and customization.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=6310524

“Healthcare segment is estimated to be the fastest-growing end-use industry for silicone elastomers market during the forecast period 2024 to 2029.”

The healthcare segment experiences rapid growth in the silicone elastomers market during forecast period, primarily due to the increasing demand for advanced medical devices and equipment. Silicone elastomers are favored in healthcare applications for their biocompatibility, durability, and flexibility. The rising prevalence of minimally invasive surgical procedures and the expanding aging population drive the need for innovative medical solutions, including silicone-based implants and devices.

Europe was the largest region for the silicone elastomers market in 2023, in terms of value.”

Europe emerges as the largest region in the silicone elastomers market owing to a combination of factors. The region benefits from a robust manufacturing sector, particularly in automotive & transportation, and electrical & electronics, where silicone elastomers find extensive applications. Stringent regulatory standards and a focus on sustainable and eco-friendly solutions drive the demand for silicone elastomers in Europe. Moreover, the region’s emphasis on innovation and technological advancements fosters the adoption of these materials in various industries, contributing to its leadership in the silicone elastomers market.

Silicone Elastomers Companies

The key market players identified in the report are Dow Inc. (US), Wacker Chemie AG (Germany), Momentive Performance Materials Inc. (US), Shin-Etsu Chemical Co., Ltd. (Japan), China National Bluestar (Group) co. Ltd. (China), Reiss Manufacturing Inc. (US), Mesgo S.p.A (Germany), Cabot Corporation (US), Rogers Corporation (US), and DuPont de Nemours, Inc. (US).

Dow Inc.

Dow Inc. (US) is a global materials science company with a diverse portfolio spanning specialty chemicals, advanced materials, and plastics. The company has a strong presence in the silicone elastomers market. Dow Inc. offers silicone elastomers under the brand names DOWSIL and SILASTIC. It caters to diverse needs of customers in industries including automotive & transportation, building & construction, electrical & electronics, foam, healthcare, consumer goods, and others. The company offers all types of silicone elastomers solutions i.e., high temperature vulcanized, room temperature vulcanized and liquid silicone rubber. Dow Inc. strategic focus on research and development, coupled with a strong market presence, positions it as a key contributor to advancements in silicone elastomers, catering to the growing needs of various industries globally.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=6310524

Momentive Performance Materials Inc.

Momentive Performance Materials Inc. (US) stands as a prominent global supplier of silicones and advanced materials, specializing in the silicone elastomers sector. Boasting a distinguished history in material science, Momentive Performance Materials Inc. is renowned for its innovative solutions across various industries, including automotive, aerospace, healthcare, and electronics. The company’s silicone elastomers, known for their versatility and high performance, find applications in demanding environments. Momentive Performance Materials Inc. unwavering commitment to research and development ensures a continual evolution of its product portfolio, addressing customer needs for durability, adaptability, and quality. The company is focused on expanding its silicone elastomers segment to satisfy consumer demand. For instance, in February 2023, Momentive Performance Materials group Inc., a global high-performance silicones and specialty solutions company, announced its latest growth investment a new manufacturing facility in Rayong, Thailand. The new investment in Rayong will help to continue to serve customers around the world, and support the industries and development in Southeast Asia,” said Pawan Sherpuri, Regional Leader, Southeast Asia.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/silicone-elastomers-market-6310524.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Silicone Elastomers Market 2025 : Impressive Growth Ahead and Trends Forecast Strong Performance by 2029 | Expert Review

Generative AI Market to Witness Notable Growth Analysis, Opportunities, and Future Scope Forecast 2032

“IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Accenture (Ireland), Capgemini (France), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), Dialpad (US), Appen (Australia).”
Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) – Global Forecast to 2032.

The generative AI market is expected to develop at a compound annual growth rate (CAGR) of 43.4% over the course of the forecast period, from an estimated USD 71.36 billion in 2025 to USD 890.59 billion by 2032. One of the main factors propelling the generative AI market is the quick development of transformer-based foundation models, which underpin numerous AI applications in various sectors. Intelligent content creation is also becoming more and more in demand, particularly in the fields of media, marketing, and customer interaction. Furthermore, the development of quick engineering tools is speeding up industry adoption by facilitating control and customization of AI outputs for enterprises.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142870584

The generative AI market is rapidly evolving into a multi-tiered commercial ecosystem, transforming how enterprises approach automation, creativity, and decision intelligence. As of 2025, the market is being driven by three key forces: foundation model delivery platforms, verticalized adoption across industries, and the rapid scaling of AI-native infrastructure. Leading providers like OpenAI, Google, and Anthropic are embedding models such as GPT-4, Claude, and Gemini into cloud-native services like Azure OpenAI, Vertex AI, and Amazon Bedrock, enabling enterprises to fine-tune, orchestrate, and deploy generative AI without heavy infrastructure overhead. This is catalyzing adoption across BFSI, retail, healthcare, manufacturing, and legal, where generative AI is being applied to use cases like fraud summarization, synthetic content creation, patient documentation, and contract analysis. Meanwhile, infrastructure demand is surging for high-bandwidth GPUs, low-latency memory systems, and vector databases optimized for retrieval-augmented generation. A new layer of differentiation is emerging through agent-based orchestration, model compression techniques, and open-weight small language models tailored to edge and on-premise environments. As global spending bifurcates between model training and inference-as-a-service, the generative AI market is entering a scale-driven phase defined by cross-layer integration, compliance-ready deployments, and high-margin platform monetization across the value chain.

Abundance of enterprise data, model maturity, and low compute overhead to cement text as largest data modality by market share in 2025

Text is the largest data modality in the generative AI market due to its foundational role in enterprise workflows, model training availability, and monetization potential. Most enterprise knowledge—emails, reports, contracts, chat transcripts, documentation, code, and knowledge bases—exists in text form, making it the most abundant and actionable input for generative models. Language models like GPT-4, Claude, and Cohere Command are specifically trained on massive corpora of unstructured text scraped from websites, books, technical manuals, and code repositories, allowing them to deliver high-performance outputs across summarization, classification, generation, and dialogue tasks. Enterprises are integrating text-based models across high-value use cases such as customer service automation, legal drafting, financial reporting, compliance explanation, and personalized marketing, where accuracy, traceability, and semantic understanding are critical. Importantly, text generation has the lowest infrastructure burden among modalities, with lower compute and storage demands compared to video or image generation. This enables faster inference, lower latency, and easier deployment across internal and customer-facing applications. With strong ecosystem support, mature APIs, and a broad set of industry benchmarks, the text remains the default and most monetizable entry point into generative AI, capturing a major share of market investment and usage.

Demand for data diversity, cost-effective labeling, and privacy compliance to push synthetic data generation to become fastest-growing application during forecast period

Synthetic data generation is poised to emerge as the fastest-growing application in the generative AI market, driven by the urgent need for diverse, high-quality, and privacy-safe datasets across industries. Traditional data collection is slow, expensive, and often constrained by regulatory barriers such as GDPR, HIPAA, or sector-specific confidentiality norms. Generative AI offers a powerful alternative by enabling the creation of labeled, unbiased, and anonymized datasets that mimic real-world scenarios without exposing sensitive information. Use cases are exploding in domains like autonomous driving, where synthetic street environments train perception systems; finance, where synthetic transactions model fraud patterns; and healthcare, where rare disease data is simulated to train diagnostic models. Enterprise adoption is surging as synthetic data accelerates model training cycles while drastically reducing dependency on manual annotation or third-party providers. Startups like Synthesis AI, Mostly AI, and Gretel.ai are scaling enterprise-ready synthetic data platforms, while hyperscalers are embedding generation capabilities directly into MLOps pipelines. With strong alignment to both AI model performance and compliance requirements, synthetic data is no longer a niche use case—it is becoming a strategic asset powering faster, safer, and more scalable AI development.

Asia Pacific to be fastest-growing market during forecast period, fueled by government backing, hyperscaler expansion, and enterprise gen AI adoption

Asia Pacific is projected to be the fastest-growing region in the generative AI market, propelled by a convergence of state-backed AI initiatives, hyperscaler infrastructure expansion, and enterprise digital transformation across high-growth economies. Countries like China, India, South Korea, Singapore, and Japan are aggressively funding generative AI R&D, launching sovereign AI models, and rolling out national compute grids to reduce dependence on Western LLMs. India’s Digital Personal Data Protection Act and initiatives like Bhashini are accelerating vernacular AI development, while firms like Infosys and TCS are embedding generative AI into BFSI, retail, and logistics workflows. In China, companies such as Baidu and Alibaba are rapidly scaling foundation models across industrial design, ecommerce, and smart cities, backed by government incentives and compute subsidies. Hyperscalers like AWS and Microsoft are adding GPU-dense cloud regions in Mumbai, Jakarta, and Seoul to meet surging demand for inference and fine-tuning. Meanwhile, the region’s massive internet user base, multilingual content diversity, and mobile-first enterprise adoption are creating high-ROI use cases in marketing automation, AI-powered customer service, and digital twins. These dynamics position Asia Pacific as the global epicenter for generative AI scale-up over the next decade.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=142870584

Unique Features in the Generative AI Market

Generative AI is rapidly evolving from single-modal (text-only or image-only) models to multimodal systems capable of understanding and generating text, images, audio, and video. This convergence allows for richer user experiences, such as AI that can interpret visual inputs and respond with natural language, or generate videos from text prompts.

Many platforms now offer fine-tuning and personalization, allowing users to train models on specific data or brand voices. This level of customization is essential for enterprise adoption, as it enables businesses to align AI outputs with their unique objectives and compliance requirements.

Advancements in model efficiency and hardware compatibility have led to real-time and edge computing capabilities, where generative AI can run on smartphones or embedded devices. This opens up applications in AR/VR, gaming, and mobile productivity tools without relying on constant internet access.

Generative AI is increasingly being integrated into collaborative platforms, such as coding assistants, design tools, and writing software. These tools enable a human-in-the-loop workflow, where the AI acts as a creative partner rather than a replacement, boosting productivity and creativity.

With growing concern around AI-generated misinformation and bias, unique safety features like reinforcement learning from human feedback (RLHF), content filters, watermarking, and usage monitoring are being embedded to ensure responsible AI deployment.

Major Highlights of the Generative AI Market

The generative AI market is experiencing exponential growth, with forecasts projecting valuations in the hundreds of billions within the next decade. This surge is driven by increased enterprise adoption, investor interest, and advancements in foundational model capabilities.

Tech giants like OpenAI, Google DeepMind, Anthropic, Meta, and Microsoft are leading the charge by developing powerful foundational models. These models serve as the backbone for a wide range of applications across sectors, from chatbots to content creation and enterprise solutions.

Generative AI is no longer confined to tech—it’s gaining traction across industries like healthcare, finance, entertainment, education, legal, and retail. Organizations are using it for tasks such as synthetic data generation, marketing automation, drug discovery, and legal summarization.

A wave of startups is entering the generative AI space, focusing on niche applications and vertical-specific solutions. These startups are innovating rapidly, supported by venture capital and cloud-native infrastructure that reduces the barrier to entry.

There has been a notable uptick in strategic partnerships, M&A activity, and capital investments. Major players are collaborating with cloud providers, chip manufacturers, and research labs to secure a technological edge and scale deployments.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=142870584

Top Companies in the Generative AI Market

Some leading players in the generative AI market include IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Accenture (Ireland), Capgemini (France), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), and Databricks (US). These companies have implemented a variety of growth strategies, both organic and inorganic. They collaborate with cloud providers, chipmakers, consulting firms, and startups to co-develop solutions and scale distribution. Additionally, they are introducing pricing models based on usage, per user, or consumption, lowering entry barriers for small and medium-sized enterprises (SMEs) and developers looking to expand their presence in the generative AI market.

Google

Google has positioned itself as a leading generative AI innovator through its Gemini multimodal foundation models, developed by its DeepMind unit and deployed via the Google Cloud Vertex AI platform. Its core competency lies in integrating advanced AI into products like Search, Workspace, and Android while also empowering enterprises through AI-as-a-service offerings. In the past three years, Google has acquired Alter (AI avatar tech), Raxium (microLED for AR), and Cameyo (cloud-native virtualization) to strengthen its AI and cloud ecosystem. Strategic partnerships with Hugging Face, Replit, and Nvidia have enabled broader model access and developer outreach. Google also launched Gemini 1.5 with Mixture-of-Experts architecture, pushing new standards in efficiency and performance. Its AI Red Team and model transparency tooling underscore a strong focus on AI governance and trust.

Microsoft

Microsoft is a major player in the generative AI market through its deep partnership with OpenAI. It has integrated OpenAI’s GPT models into its products, like Microsoft 365 Copilot, GitHub Copilot, and Azure OpenAI Service. These tools help users write emails, generate code, and automate business tasks. Microsoft Azure offers cloud-based access to generative AI models, allowing businesses to build and scale AI applications. The company has invested over USD 10 billion in OpenAI and is embedding generative AI across productivity, development, and enterprise tools. Microsoft also works with companies like SAP and Oracle to expand AI use in business solutions.

IBM

IBM is actively advancing in the generative AI market through its enterprise-focused platform, watsonx. This platform integrates proprietary, third-party, and open-source models, enabling businesses to deploy and fine-tune AI applications across various domains, including customer service, application modernization, and IT operations. IBM’s consulting division plays a pivotal role, accounting for approximately 75% of its generative AI business, which has surpassed $2 billion in total bookings since the platform’s inception. The company emphasizes a hybrid, multi-cloud approach, offering clients flexibility in deployment and customization. Additionally, IBM’s open-source strategy enhances scalability and cost-effectiveness, positioning the company as a significant player in the enterprise generative AI landscape.

NVIDIA

NVIDIA is a leading force in the generative AI market, offering a comprehensive suite of tools and platforms tailored for enterprise applications. The company provides the NVIDIA AI Enterprise software suite, which includes frameworks like NeMo for building large language models (LLMs) and NIM microservices for inference optimization. These tools are integrated with cloud services such as Microsoft Azure and VMware, enabling businesses to develop, deploy, and manage custom AI applications securely and efficiently . NVIDIA’s DGX Cloud Lepton further enhances accessibility by connecting developers to a network of GPU cloud providers, facilitating scalable AI development . Collaborations with companies like SAP and Cloudera have expanded NVIDIA’s reach, allowing enterprises to leverage their data for advanced AI applications . Additionally, NVIDIA’s hardware solutions, such as the Blackwell Ultra GPUs, power high-performance AI servers, underscoring its pivotal role in the generative AI ecosystem.

OpenAI

OpenAI, headquartered in San Francisco, is a leading force in the generative AI market, renowned for its suite of advanced AI models including GPT-4o, DALL·E, Codex, and Sora. The company offers these models through APIs and enterprise solutions like ChatGPT Enterprise, enabling businesses to integrate AI capabilities into their operations. OpenAI’s strategic partnerships, notably with Microsoft, have facilitated the embedding of its models into platforms such as Azure AI and GitHub Copilot. In a significant move to expand into hardware, OpenAI acquired Jony Ive’s startup, io, in a $6.5 billion deal, aiming to develop AI-integrated devices like wearables and robots. The company also launched the GPT Store, a platform allowing users to create and monetize custom AI chatbots without advanced programming skills. Additionally, OpenAI is a key player in the Stargate Project, a $500 billion initiative to build AI infrastructure in the U.S., in collaboration with SoftBank, Oracle, and others.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/generative-ai-market-142870584.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Generative AI Market to Witness Notable Growth Analysis, Opportunities, and Future Scope Forecast 2032

Traffic Management Market Trends, Top Company Analysis, Regional Trends, Competitive Landscape, and Industry Potential by 2029

“Cisco (US), Mundys SpA (Italy), SWARCO (Austria), Siemens (Germany), IBM (US), Kapsch TrafficCom (Austria), Thales Group (France), Q-Free (Norway), PTV Group (Germany), Teledyne FLIR Systems Inc. (US), Cubic Corporation (US), TOMTOM (Netherlands), Huawei (China).”
Traffic Management Market by Solution (Traffic Monitoring & Analytics, Adaptive Traffic Control, Traffic Enforcement Management, Incident Detection & Management) and End-User (Government, Private) – Global Forecast to 2029.

The traffic management market is projected to expand at a compound annual growth rate (CAGR) of 11.7% from USD 43.53 billion in 2024 to USD 75.74 billion by 2029. Transport-related emissions are decreased via the operation of traffic management systems with adaptive signals and intelligent parking systems. Carpooling and the use of electric vehicles are two ways that urban regions are fostering sustainable transportation systems that collaborate with Intelligent Transportation Systems (ITS) to lessen their impact on the environment. Through their efforts to reduce pollution, these programs safeguard the environment and public health, which motivates the installation of traffic management systems.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1036

Governments worldwide have strong visions of improving traffic management across cities and fulfilling future mobility demands. They are undertaking several initiatives to provide better infrastructures, enhance security and safety, and offer seamless traffic flow. These factors are strong indicators of the economic development of a region. Smart city and intelligent transportation initiatives have boosted the traffic management market. For instance, the Land Transport Authority (LTA), Singapore, along with Intelligent Transportation Society Singapore (TSS), has developed a master plan, Smart Mobility 2030, to enhance the travelers’ experience and the country’s existing transportation systems. Regional governments are encouraging private companies to develop and renovate road infrastructures. Governments are working with private organizations to finance and deliver traffic management projects.

The private enterprise end-user is projected to register the highest CAGR during the forecast period.

Private enterprises use advanced traffic solutions to make their operations more effective and create better customer experiences while saving money. Businesses that run logistics, transportation, retail, and entertainment services depend on good traffic flow to ensure deliveries arrive on time and give customers easy access while running their operations well. Private companies use Intelligent Transportation System (ITS) and traffic data technology to plan better routes and control their vehicle fleets while offering automated parking systems to their customers. Big shopping malls, sports stadiums, and business campuses use traffic management systems to handle crowds during busy times. These solutions improve operations, benefiting the environment and boosting company profits.

Implementation services are estimated to contribute the largest market share of traffic management market.

The implementation services install and connect advanced solutions to improve traffic management while making roads safer and less congested. This involves installing ITS, traffic lights that adapt to conditions, video cameras for surveillance, and Vehicle-to-Everything (V2X) networking hardware. Service providers link new technology to current systems to solve problems at both urban and intercity traffic levels. Service providers configure systems and test operations while teaching authorities how to use the new systems. The implementation services segment helps update transportation systems to reach permanent mobility objectives through real-time monitoring and automated traffic management.

Based on region, Asia Pacific is projected to register the highest CAGR during the forecast period.

Asia Pacific, home to nearly 40% of the world’s population, is witnessing diverse implementations of traffic management technologies. Fast urban growth and rising population numbers make traffic management difficult across the Asia Pacific. Densely populated countries such as China and India deal with severe traffic congestion problems. Asia holds six of the world’s top ten congestion hotspots, and Bengaluru and Manila stand out among them. Various Asian nations are implementing major traffic management projects to solve transportation problems through initiatives such as Australia’s Gateway WA Perth Airport and India’s Smart City Kochi. These projects work to upgrade transportation systems and make traffic easier to handle. Modern sensors and internet connectivity help analyze real-time traffic data to develop advanced management systems while giving drivers accurate info to avoid traffic delays.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1036

Unique Features in the Traffic Management Market

A defining feature of the traffic management market is the integration of intelligent transportation systems. These systems utilize real-time data, sensors, and communication technologies to monitor, control, and optimize traffic flow. ITS enables proactive traffic responses, reducing congestion and improving overall road safety.

ATCS are a standout innovation, dynamically adjusting signal timings based on real-time traffic conditions. This feature allows cities to respond to traffic fluctuations with precision, minimizing delays and travel time while optimizing signal coordination across intersections.

Artificial intelligence and machine learning are increasingly being used to forecast traffic patterns, predict congestion, and manage incidents. These technologies provide predictive insights that help authorities plan and allocate resources more efficiently.

The market is seeing the rise of connected vehicles that communicate with traffic infrastructure and each other. This vehicle-to-everything (V2X) communication improves situational awareness, enabling better traffic flow, fewer accidents, and enhanced commuter experience.

Real-time data analytics is a cornerstone of modern traffic management. By collecting data from GPS, mobile apps, road sensors, and surveillance cameras, traffic authorities can gain actionable insights, leading to informed decisions and strategic planning.

Major Highlights of the Traffic Management Market

With the accelerating pace of urbanization worldwide, cities are facing mounting pressure to manage growing traffic volumes. This has led to a significant increase in the adoption of advanced traffic management solutions aimed at reducing congestion, improving road safety, and enhancing mobility.

Governments across the globe are investing heavily in smart city infrastructure, with traffic management systems being a key focus area. Public-private partnerships and funding initiatives are enabling large-scale deployments of intelligent traffic systems to modernize transportation networks.

The market is witnessing continuous technological evolution with the integration of AI, IoT, machine learning, and big data analytics. These technologies are enhancing the accuracy, efficiency, and predictive capabilities of traffic control systems, enabling real-time management and data-driven decisions.

There is a notable trend toward adaptive traffic control and automated incident detection. These systems dynamically respond to changing traffic conditions, reducing manual intervention and improving overall traffic efficiency.

Environmental concerns are pushing the market toward sustainable traffic management practices. Solutions that minimize emissions, support public transportation, and facilitate non-motorized mobility (like cycling and walking) are gaining traction.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1036

Top Companies in the Traffic Management Market

The major vendors covered in traffic management market include Cisco (US), Mundys SpA (Italy), SWARCO (Austria), Siemens (Germany), IBM (US), Kapsch TrafficCom (Austria), Thales Group (France), Q-Free (Norway), PTV Group (Germany), Teledyne FLIR Systems Inc. (US), Cubic Corporation (US), TOMTOM (Netherlands), Huawei (China), ST Engineering (Singapore), ChevronTM (England), Indra Sistemas (Spain), and Econolite (US). These firms have used various growth methods, including partnerships, agreements, business expansions, collaborations, and the introduction of new products, to increase the prominence of the traffic management market.

Mundys SpA

Mundys SpA, previously known as Atlantia SpA, is an Italian holding company that constructs and operates motorways, airports, and transport infrastructure, parking areas, and intermodal systems worldwide, through its subsidiaries. It operates and manages approximately 9,125 kilometers of toll motorways and supports Italian motorway operators. The company manages, maintains, constructs, and widens related motorways operated under concession. It also operates and expands Rome’s Fiumicino and Ciampino airports, as well as the airports of Nice, Cannes-Mandelieu, and Saint-Tropez.

Additionally, Mundys SpA engages in the design, project management, control, and maintenance of road and airport infrastructures. It operates toll payment systems, offers assistance and toll management services, and provides insurance brokerage and engineering services. The company also operates free-flow tolling, traffic and transport management, and electronic payment systems. In January 2022, the Company acquired Yunex Traffic from the Siemens Group. Yunex Traffic is the global leader in Intelligent Transport Systems (ITS) and Smart Mobility solutions, which specialize in developing and supplying integrated hardware and software platforms and solutions for the operators of smart and sustainable mobility infrastructure serving urban and out-of-town areas. Mundys SpA was formerly known as Atlantia SpA and changed its name to Mundys SpA in March 2023.

SWARCO

SWARCO is a family-owned company with over 50 years of experience in traffic management innovation. Its products and services aim to provide safe, fast, and hassle-free travel experience. The Austrian Traffic Technology Corporation produces and offers various products and services, including solutions for road marking, urban traffic management, parking management, and public transport. The company plans to create cooperative systems, infrastructure-to-vehicle communication, eMobility, and integrated software solutions for smart cities to manage traffic effectively. With a team of 4,000 traffic experts, the company shapes the traffic industry and provides value-added services to the digital world’s travelers. The international group provides a complete range of products, systems, services, and solutions for road safety and intelligent traffic management. It specializes in traffic management and safety and provides various signals, displays, and lighting products. Services such as consultancy, planning, execution, system integration, installation, service, and maintenance are also provided. The company has a global presence, offering products and services in over 80 countries.

Cisco

Cisco (US) is a significant player in the Traffic Management Market, offering innovative networking, IoT, and AI-powered solutions to optimize traffic flow, reduce congestion, and increase road safety. The company provides smart traffic management systems that maximize urban mobility by combining real-time data analytics, edge computing, and cloud-based infrastructure. Cisco’s Connected Roadways and Smart City initiatives leverage AI, 5G, and automation to enhance traffic signal control, vehicle-to-infrastructure (V2I) communication, and predictive analytics, helping cities worldwide build efficient and sustainable transportation networks.

Siemens

Siemens (Germany) is a traffic management market leader, providing AI-driven, IoT-enabled, and cloud-based solutions to improve urban mobility and reduce congestion. Siemens Mobility offers intelligent traffic systems (ITS), adaptive traffic control, and smart intersection management to help improve traffic flow in real time. Siemens’ Sitraffic® platform uses AI, 5G, and edge computing to enhance vehicle-to-infrastructure (V2I) communication, automated traffic signal control, and predictive analytics. By concentrating on sustainable and efficient transportation, Siemens is assisting cities around the world in transitioning to smart mobility ecosystems.

IBM

IBM (US) is a major player in the Traffic Management market, using AI, cloud computing, and IoT to improve urban mobility and minimize traffic congestion. The company optimizes road networks by providing real-time traffic analytics, predictive modeling, and AI-powered automation via IBM Watson and IoT-driven smart traffic solutions. IBM’s Intelligent Transportation Systems (ITS) make use of big data, edge computing, and machine learning to improve traffic forecasting, incident management, and vehicle-to-infrastructure (V2I) communication. IBM is accelerating innovation in smart city traffic management by combining blockchain for safe data exchange and 5G for real-time monitoring.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/traffic-management-market-1036.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Traffic Management Market Trends, Top Company Analysis, Regional Trends, Competitive Landscape, and Industry Potential by 2029

Organic Fertilizers Market Outlook 2024–2029: Growth Drivers, Trends, and Key Players

“MarketsandMarkets™”
Organic Fertilizers Market Size, Share, Industry Growth, Trends Report by Source (Plant, Animal, Mineral), Form (Dry and Liquid), Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables), and Region – Global Forecast to 2029

The global organic fertilizers market is valued at USD 7.9 billion in 2024 and is projected to reach USD 13.6 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.5% during the forecast period. This growth is driven by evolving consumer preferences, heightened environmental awareness, and innovations in agricultural practices.

Consumers are increasingly wary of the health risks posed by chemical fertilizers and synthetic additives used in conventional farming. As a result, there is a growing shift towards organic food products, which are perceived as healthier and safer. This trend is fueling demand for organic fertilizers, which are derived from natural sources such as compost, manure, and plant residues. These fertilizers not only improve soil fertility and health but also reduce the risk of environmental degradation, aligning with the global shift toward sustainable and eco-friendly farming methods.

 

Organic Fertilizers Market

 

Organic Fertilizers Market Drivers

  1. Rising Demand for Organic Food: Consumers are increasingly choosing organic produce due to health concerns and environmental awareness. This surge has prompted farmers to adopt organic fertilizers to meet certification standards and consumer expectations.
  2. Soil Degradation and Environmental Concerns: Overuse of chemical fertilizers has led to soil acidification, loss of biodiversity, and water pollution. Organic fertilizers help restore soil health and reduce harmful environmental impacts.
  3. Government Regulations and Incentives: Many governments worldwide are encouraging sustainable farming practices by offering subsidies, grants, and regulatory frameworks favoring organic inputs.
  4. Advancements in Organic Fertilizer Technology: Innovations in processing organic waste and biofertilizer development have enhanced the efficiency and ease of use of organic fertilizers.

 

Organic Fertilizers Market Trends

  1. Increasing Adoption in Developing Countries: Regions such as Asia-Pacific and Latin America are witnessing rapid growth as smallholder farmers embrace organic farming to improve yields and soil fertility.
  2. Integration with Precision Agriculture: Combining organic fertilizers with precision farming technologies helps optimize nutrient delivery, reducing waste and enhancing productivity.
  3. Expansion of Distribution Channels: E-commerce platforms and specialized agricultural supply stores are making organic fertilizers more accessible to farmers worldwide.

 

Liquid Organic Fertilizers: Fastest-Growing Segment

The liquid segment is expected to grow at the highest CAGR during the forecast period. This surge is driven by the growing adoption of precision agriculture and the demand for fertilizers that are easy to apply and highly effective. Liquid organic fertilizers provide uniform nutrient distribution and faster plant absorption, making them a preferred choice for farmers aiming to boost yields while maintaining sustainable practices. As agricultural operations scale up, demand for these convenient and efficient formulations is set to rise further.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171744317

Mineral-Based Organic Fertilizers: Steady Growth

The mineral source segment is projected to maintain consistent growth through 2029. These fertilizers supply essential nutrients such as potassium, phosphorus, and calcium—crucial for plant development. Sourced from natural mineral deposits, they also help improve soil structure and fertility over time. With growing emphasis on long-term soil health and sustainable nutrient management, mineral-based organic fertilizers remain a reliable solution for organic farming, supporting stable market expansion.

North America Dominates the Organic Fertilizers Market Share.

North America holds the largest share of the global organic fertilizers market. This leadership is driven by rising consumer demand for organic foods, strict regulations on synthetic inputs, and increasing adoption of sustainable farming practices. Farmers in the region are embracing organic methods to comply with regulations and meet eco-conscious consumer expectations. With continued investments in organic agriculture and improved access to organic fertilizer products, North America is expected to maintain its dominant position throughout the forecast period.

Leading Organic Fertilizers Companies:

Key players in this market include Yara (Norway), ICL (Israel), K+S Aktiengesellschaft (Germany), The Scotts Company LLC (US), Coromandel International Limited (India), Darling Ingredients (US), SPIC (India), T.Stanes and Company Limited (India), Fertoz (Australia), Multiplex Group Of Companies (India), TerraLink Horticulture Inc. (Canada), Midwestern Bio Ag Holdings, LLC (US), Suståne Natural Fertilizer, Inc. (US), Queensland Organics (Australia), and California Organic Fertilizers, Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/organic-fertilizer-Market-171744317.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Organic Fertilizers Market Outlook 2024–2029: Growth Drivers, Trends, and Key Players

Egg Processing Market Trends, Growth Drivers, Key Segments, and Future Outlook

“MarketsandMarkets™”
Egg Processing Market by product type (Dried Egg Products, Liquid Egg Products, Frozen Egg Products), End-use Application (Food Processing and Manufacturing, Food Service, Retail), Nature and Region – Global Forecast to 2029

The egg processing market is valued at approximately USD 33.3 billion in 2024 and is expected to grow to USD 41.9 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.7% during this period. Several factors influence the global egg processing market’s development, including shifts in consumer preferences, advances in processing technologies, and evolving food safety regulations. Additionally, population growth, urbanization, and changing dietary habits significantly impact the demand and supply dynamics within this sector.

 

Egg Processing Market

 

A notable study published in October 2022 in Frontiers in Animal Science examined consumer perceptions of egg processing across 14 countries, such as Australia, Brazil, China, India, Malaysia, Nigeria, the UK, and the US. Drawing on responses from 4,292 participants, the research revealed detailed insights into consumer attitudes toward egg production systems and hen welfare. An overwhelming 76% of respondents (excluding Nigeria) favored eggs from hens raised in cage-free environments. Furthermore, 72% highlighted the importance of minimizing hen suffering during egg production, underscoring a widespread concern for animal welfare. These insights offer valuable guidance to industry players and animal welfare advocates aiming to align production practices with consumer expectations.

In response to these shifting preferences, leading producers like Cal-Maine Foods and Rose Acre Farms have been investing heavily in cage-free production systems. Cal-Maine Foods, one of the largest egg producers in the U.S., is expanding its cage-free operations to meet growing demand for ethically sourced eggs. Similarly, Rose Acre Farms has committed to transitioning all its hens to cage-free housing by 2026, emphasizing their dedication to animal welfare and ethical sourcing.

The egg processing industry continues to evolve, driven by trends such as rising demand for cage-free and organic eggs, advancements in processing technologies that improve product quality, and growing focus on sustainability and traceability. Technology adoption aimed at boosting operational efficiency also plays a critical role. Staying informed about these developments is essential for stakeholders to capitalize on new opportunities and navigate the dynamic landscape of the egg processing market.

Egg Processing Market Growth Drivers

  1. Rising Demand for Convenience Foods: Busy lifestyles and urbanization have led consumers to seek quick and easy meal solutions. Processed egg products such as liquid eggs and powdered eggs offer convenience for food manufacturers and restaurants, speeding up preparation times.
  2. Health and Nutrition Awareness: Eggs are a rich source of high-quality protein, vitamins, and minerals. Processed egg products enable easier integration into various health-oriented food products such as protein bars, supplements, and infant nutrition formulas.
  3. Expansion of Foodservice Industry: The global growth of cafes, bakeries, fast food chains, and catering services drives demand for consistent, safe, and easy-to-use egg products.
  4. Technological Advancements: Improvements in egg pasteurization, drying, and packaging technologies have enhanced the safety, shelf life, and quality of processed egg products, making them more appealing to consumers and manufacturers alike.

 

The organic egg products segment is poised for rapid growth over the coming years.

Rising consumer demand for organic egg products is fueled by increasing awareness around health benefits, food safety, animal welfare, and environmental sustainability. Data from the United Egg Producers highlights this trend: Organic and cage-free shell egg production climbed from 29.3% (96.1 million hens) in 2021 to 34% (106.2 million hens) in 2022. This growth reflects consumers’ growing concerns about the humane treatment of food animals. Organic certification standards ensure hens have outdoor access and are raised without antibiotics or growth hormones, appealing to ethically minded buyers.

Insights from the Egg Carton Store Blog (September 2023) further underscore the surge in organic egg product demand, driven by health-conscious shoppers seeking premium, ethically produced food. Many consumers are willing to pay a premium for organic eggs due to their perceived superior quality and sustainable production methods. Factors such as rising disposable incomes, wider product availability, and strategic marketing efforts are amplifying this growth. For example, EIPRO-Vermarktung GmbH & Co. KG (Germany) offers a broad portfolio of organic egg products—including whole eggs, yolks, whites, as well as liquid and frozen egg alternatives—all pasteurized for safety and available in various packaging formats.

Asia Pacific Dominates the Egg Processing Market Share.

The Asia Pacific (APAC) egg processing market includes key countries such as Japan, China, India, Australia, New Zealand, and others in the region. According to a 2023 article by WATT Poultry, the outlook for Asia’s poultry and egg producers remains optimistic. This positive trajectory is supported by rising incomes, rapid urbanization, enhanced disease control measures, and the integration of advanced technologies, which collectively create favorable long-term conditions for growth.

Nevertheless, the sector faces ongoing challenges like price volatility, stricter animal welfare regulations, and mounting pressure to adopt sustainable practices amid growing environmental concerns. Persistent disease threats also demand continued innovation and investment in biosecurity to protect poultry health and maintain market stability. These multifaceted issues highlight the importance of strategic planning and cross-industry collaboration within the APAC poultry and egg sectors.

Leading Egg Processing Companies:

Prominent industry players, including Cal-Maine Foods, Inc. (US), Rose Acre Farms (US), Ovobel Foods Limited (India), SKMEgg.com (India), Interovo Egg Group BV (Netherlands), IGRECA (France), Eurovo Srl (Italy), Avril SCA (France), Rembrandt Foods (US), and Hillandale Farms (US), wield substantial influence in the egg processing market. These entities boast robust manufacturing facilities and well-established distribution networks across pivotal regions such as North America, Europe, South America, and the Asia Pacific, ensuring a widespread presence and accessibility of their products.

Future Outlook

The egg processing market is poised for innovation and growth, driven by continued demand for protein-rich and convenient foods. Key trends to watch include:

  1. Development of organic and specialty egg products catering to health-conscious consumers.
  2. Adoption of clean-label and allergen-free processed eggs.
  3. Increased use of automation and AI in egg processing plants for improved efficiency.
  4. Expansion of processed egg applications in nutraceuticals and cosmetics.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124810046

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/egg-processing-equipment-market-124810046.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Egg Processing Market Trends, Growth Drivers, Key Segments, and Future Outlook

Plant-Based Supplements Market Outlook 2025-2030: Key Trends, Growth Drivers, and Regional Insights

“MarketsandMarkets™”
Plant-based Supplements Market by Product Type (Protein, Vitamins & Minerals, Superfood & Functional, Prebiotics & Probiotics, Ready-to-Drink (RTD), Snacks), Supplement Form, Age Group, End-use, Distribution Channel, and Region – Global Forecast to 2030

The plant-based supplements market is estimated at USD 27.52 billion in 2025 and is projected to reach USD 42.27 billion by 2030, at a CAGR of 9.0% from 2025 to 2030. The plant-based supplement market is seeing strong demand beyond basic products like multivitamins and protein powders. Consumers increasingly seek specialized health options for weight loss, hormonal balance, mental well-being, and stress relief. This focus on personalized wellness has led to innovative ingredient combinations and various formats, such as powders, gummies, and capsules. Savvy consumers prefer products with transparent labeling, science-backed claims, and sustainably sourced ingredients, transforming plant-based supplements into essential components of tailored health regimens. The growth of e-commerce and direct-to-consumer businesses has also boosted their popularity, allowing customers to research, compare brands, and read reviews online. Subscription services and influencer marketing encourage repeat purchases and brand loyalty, while wider availability in health food stores, pharmacies, and supermarkets ensures market growth. As awareness of plant-based living rises, convenience and variety will continue to drive the market forward.

 

 Plant-based Supplements Market

 

Plant-based Supplements Market Driver: Increasing consumer focus on preventive healthcare and wellness

Rising consumer demand for wellness and preventive healthcare is significantly boosting the market for plant-based supplements, including botanicals, functional foods, herbal extracts, and vitamins. These products are considered holistic, safe, and natural for enhancing immunity, digestion, energy, and overall health. The clean-label trend—favoring products without synthetic additives or animal-derived ingredients—is particularly popular among younger, health-conscious consumers and vegetarians. Companies like Herbalife International, Garden of Life, and Nature’s Bounty are expanding their lines to include plant protein powders, adaptogenic plants, and vegan multivitamins. In June 2024, Megafoods introduced a plant-based Omega 3-6-9 supplement made from algae oil and Ahiflower, designed for heart, brain, eye, and joint health. This sustainably produced, fish-free product contains 600 mg of omega-3s, is Non-GMO Project certified, and is allergen-free for better taste and digestibility.

Protein supplements are estimated to account for a significant share of the market by product type

Protein supplements are maintaining a significant market share in the plant-based supplement segment, fueled by a growing interest in clean, green, and allergy-free protein sources. As more people move away from animal products for health, ethical, and environmental reasons, plant-based protein alternatives like pea, rice, hemp, and soy have gained immense popularity. These sources provide exceptionally high nutritional value and improved digestibility and are often enriched with amino acids to match the profiles of traditional proteins. Additionally, the rising trend of fitness, weight management, and active lifestyles among both flexitarians and vegans has greatly increased the demand for plant protein supplements. Their widespread use in meal replacements, sports nutrition, and functional foods drives their leading market share.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239782374

The adults (18–64 years) segment holds a significant share in the market, by age group.

The adults (18–64 years) segment represents a significant market share in the plant-based supplements industry, driven by rising health awareness and a proactive approach to well-being. Adults are increasingly choosing plant-based supplements to enhance immunity, energy, stress management, and overall wellness. With the prevalence of lifestyle diseases like obesity and diabetes, many are turning to natural remedies instead of conventional medications. This age group values clean-label, chemical-free products, reflecting a broader trend towards plant-based diets and sustainable living. They are also more open to new eating styles, such as vegan and flexitarian diets, which boosts demand for plant-based nutritional solutions. As a major part of the workforce, adults prioritize convenience and preventive care. Plant-based supplements are seen as practical aids for maintaining productivity and mental alertness in high-stress lifestyles. Social media and online retailers have raised awareness and access to these products, especially among tech-savvy consumers.

Asia Pacific is projected to grow at a significant rate in the plant-based supplements market.

The Asia Pacific plant supplements market is growing rapidly due to increased health awareness, a rising vegetarian and vegan population, and higher disposable incomes. Dominated by China, India, Japan, and Australia, consumers are opting for clean-label, nature-based supplements that enhance immunity, energy, and well-being. Health claims and organic certifications help build consumer trust. The market is expected to expand further, driven by innovations in plant-based supplements and proteins. In March 2024, the International Probiotics Association reported that the Asia Pacific region accounted for 42% of global probiotic supplement sales in 2023, amounting to USD 3.7 billion. With a CAGR of 15.8% from 2019 to 2023 and projected growth of USD 1.77 billion from 2024 to 2028, this region leads global demand for probiotics, surpassing other areas despite the U.S. holding the largest individual market. This trend reflects shifting consumer focus towards digestive health and plant-based wellness. As probiotics gain popularity, manufacturers will likely enhance their portfolios with plant-based ingredients, making Asia-Pacific a key growth market for functional supplements.

Leading Plant-based Supplements Companies:

The report profiles key players such as Nestle (Switzerland), Abbott (US), Glanbia PLC (Germany), Otsuka Holdings Co., Ltd. (Japan), Herbalife Ltd. (US), H&H Group (China), Jamieson Wellness Inc (Canada), NOW Foods (US), The Schwabe Group (Germany), Gaia Herbs Farm (US), Nordic Naturals (US), ProCaps Laboratories, Inc. (US), Sunwarrior LLC (US), Nutrex Hawaii (China), and Navitas Organics (US).

Recent Developments of Plant-based Supplements Industry:

  1. The Schwabe Group of Germany in March 2025 took a majority stake in Berlin-headquartered Braineffect, further consolidating its leadership in the nutrition supplement and functional food segment. Expanding on its first investment in 2020, Schwabe hopes to utilize Braineffect’s disruptive brand to tap into new consumers while founder Fabian Foelsch continues to drive future growth.
  2. In December 2023, US-based Pharmavite, LLC, a subsidiary of Otsuka Holdings (Japan), acquired Bonafide Health, LLC (US). The acquisition expanded Pharmavite’s offerings with women’s health products; Pharmavite already offers brands such as Ugora and Equelle.
  3. In August 2023, Herbalife (US) launched Herbalife V, a new line of plant-based supplements developed through robust research and innovation. The portfolio includes five USDA Organic, non-GMO, and vegan-certified products: protein shakes with 20 g of plant-based protein, a nutrient-dense greens booster, and specialized formulas for immune and digestive support.

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=239782374

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/plant-based-supplements-market-239782374.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Plant-Based Supplements Market Outlook 2025-2030: Key Trends, Growth Drivers, and Regional Insights

Precision-Guided Munition Market worth $49.71 Billion by 2030, at a CAGR of 5.9%

“Precision-Guided Munition Market”
The Precision-Guided Munitions Market Value is projected to be USD 49.71 billion by 2030, growing from USD 37.24 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.

The report “Precision-Guided Munition Market by Product (Tactical Missile, Interceptor Missile, Torpedoes, Rockets, Loitering Munition), System (Guidance & Navigation, Target Acquisition), Launch Platform, Speed, Mode of Operation, Region – Global Forecast to 2030” The precision-guided munitions market is estimated to be USD 37.24 billion in 2025 and is projected to reach USD 49.71 billion by 2030, at a CAGR of 5.9%. Precision-guided munitions represent a rapidly evolving domain within the defense sector, characterized by the integration of advanced targeting technologies, autonomous guidance systems, and modular warhead configurations. PGMs enable defense forces to transition from conventional volume fire tactics to high-precision, low-collateral, and scalable strike capabilities across land, air, and sea platforms.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=109859417

Browse 200 market data Tables and 100 Figures spread through 230 Pages and in-depth TOC on “Precision-Guided Munition Market”

View detailed Table of Content herehttps://www.marketsandmarkets.com/Market-Reports/precision-guided-munition-market-109859417.html

This shift is supported by the growing need to improve operational efficiency, enhance strike effectiveness, and minimize the broader tactical and political risks associated with conventional bombardment strategies. PGMs are widely adopted across platforms ranging from unmanned aerial systems and fighter aircraft to mobile artillery and naval launchers.

Based on guided ammunition, the guided artillery shells segment is expected to grow at the highest CAGR during the forecast period.

Guided artillery rounds are a rapidly developing niche within the precision-guided munitions (PGM) market, offering revolutionary ground-based fires. They match the range and destructive power of traditional artillery with the precision of sophisticated guidance systems, providing first-round effects and significantly minimizing ammunition consumption, mission time, and collateral damage.

Artillery has in the past been employed for area suppression or volume fire missions. Guided artillery rounds, however, offer precision targeting of high-value targets like command posts, mobile air defenses, and dug-in positions, without needing multiple adjustments or salvos. GPS/INS, laser, or terminal homing sensors direct these rounds to maintain high accuracies at extended ranges, even in dynamic or contested environments.

The M982 Excalibur, Vulcano, and Krasnopol systems are in the process of being deployed or are in a mature development stage with backward compatibility to current 155 mm and 152 mm howitzers. Backward compatibility allows for swift increases in firepower without platform replacement, which is an attractive modernization option.

Programmable shells are especially useful in GPS-denied areas or in urban combat, where accuracy is crucial and traditional rounds are too dangerous. In addition, the combination of programmable fuzes, target data links, and AI-assisted targeting is increasing the tactical utility of these rounds across a range of mission profiles.

Based on product, the loitering munitions segment is projected to grow at the highest CAGR during the forecast period.

Loitering munitions are becoming one of the most rapidly growing and disruptive segments in the Precision-Guided Munitions Industry because of their singular capability to integrate real-time reconnaissance, target recognition, and strike within a single, lightweight system. These munitions, commonly referred to as “kamikaze drones,” are engineered to loiter or patrol over a target zone for hours, or even days, waiting for high-value or time-critical targets to materialize before striking with precision.

Their two-fisted capability of intelligence, surveillance, and reconnaissance (ISR), followed by a rapid strike, gives loitering munitions an operational and tactical advantage over their conventional PGM counterparts, which involve pre-plotted target coordinates. They are highly useful in liquid, decentralized, or asymmetric theaters, where the battlefield is liquid and threats are mobile.

Based on region, North America is expected to account for the largest market share during the forecast period.

North America will hold the highest percentage in the global precision-guided munitions market because of its unparalleled defense manufacturing base, consistent military spending, and strategic focus on advanced cutting-edge precision strike technology. Historically, the focus has been on precision rather than merely on numbers when it comes to military policy. As a result, precision-guided munitions have become a cornerstone of force presentation strategy across all militarily significant domains: land, air, sea, and space.

The United States Department of Defense alone is the largest purchaser and producer in the PGM market, sustaining a healthy pipeline of programs in tactical missiles, smart bombs, loitering systems, and extended-range fires. Flagship programs like JDAM, GMLRS, StormBreaker, JAGM, and PrSM are not only used nationally but also exported abroad, supporting the North American dominance in world standards and interoperability.

North America is also blessed with the presence of top defense contractors like Lockheed Martin, RTX, Boeing, and Northrop Grumman, who have advanced expertise in areas such as guidance systems, propulsion, modular munitions, and AI-targeting. These kinds of organizations are constantly breaking the boundaries of innovation and developing long-term partnerships with defense agencies to implement future PGMs rapidly, with testing and development.

Key Players

Northrop Grumman (US), RTX (US), General Dynamics Corporation (US), BAE Systems (UK), Lockheed Martin Corporation (US), MBDA (France), Israel Aerospace Industries (Israel), QinetiQ (UK), Boeing (US), and Aselsan AS (Turkey), are some of the leading players in the Precision-Guided Munitions Companies. These companies have well-equipped manufacturing facilities and strong distribution networks across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/precision-guided-munition-market-109859417.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Precision-Guided Munition Market worth $49.71 Billion by 2030, at a CAGR of 5.9%

Juice Testing Market to Reach $1.28 Billion by 2030: Trends, Growth Drivers, and Key Players

“MarketsandMarkets™”
Juice Testing Market by Product Type (Fruit Juices, Vegetable Juices, Concentrates), Technology (Manual Testing Technologies and Instrument-based Testing Technologies), Test Type (Microbial Testing, Chemical Testing), and Region – Global Forecast to 2030

The juice testing market is estimated at USD 0.86 billion in 2025 and is projected to reach USD 1.28 billion by 2030, at a CAGR of 8.2% from 2025 to 2030. The juice testing market is experiencing steady growth due to rising consumer awareness about food safety, increasing incidences of contamination, and strict global regulatory standards. Manufacturers are adopting advanced testing methods to ensure product quality, prevent health risks, and maintain brand reputation. The demand for testing has also been driven by the expanding juice industry, with product launches and innovations requiring rigorous safety evaluations. Additionally, growing health consciousness and preference for natural beverages have increased scrutiny of juice ingredients and processing methods. These factors collectively drive the need for comprehensive testing solutions across microbial, chemical, and sensory parameters.

 

Juice Testing Market

 

Why Juice Testing Matters?

  1. Food Safety Compliance: Juices are susceptible to microbial contamination, especially due to their high sugar and moisture content. Regulatory bodies like the FDA, EFSA, and FSSAI require rigorous testing for pathogens such as E. coli, Salmonella, and Listeria monocytogenes. Juice testing helps brands comply with these standards, reducing the risk of recalls and legal penalties.
  2. Quality Assurance and Brand Trust: Accurate testing ensures the juice meets label claims for vitamins, sugar content, and additives. In an era of label-conscious consumers, this transparency builds consumer trust and brand loyalty.
  3. Combatting Adulteration: The growing trend of premium, organic, and cold-pressed juices has made the market attractive for counterfeits and adulteration. Testing helps identify dilution, synthetic additives, and mislabeled origin or fruit types.

 

Juice Testing Market Drivers: Increasing incidences of contamination and foodborne illnesses driving stricter regulatory requirements

The expansion of the juice testing market is largely contributed to by increasing public health alarms about juice contamination, which has been a recurring problem since the early 1990s. Based on a Journal of Food Protection report (2022), the CDC reported 21 juice-associated outbreaks in the US from 1995 to 2005, causing 1,366 illnesses. Pathogens such as E. coli O157:H7, Salmonella, and Cryptosporidium were the most frequently associated with these outbreaks, with apple and orange juice being the principal sources. As a consequence, the US FDA rolled out HACCP-based regulations on juice safety in phases from 2002 to 2004. These regulatory measures, combined with consumers’ pressure for safer drinks, have stimulated microbial and contaminant testing service growth. This highlights the pivotal task of sound juice testing to ensure public health and uphold industry regulatory standards.

By test type, the chemical testing segment holds a significant market share in the global juice testing market.

Chemical testing holds a significant share of the juice testing market, driven by its vital role in verifying product composition, safety, and regulatory compliance. Producers routinely rely on chemical analyses—acidity, preservative levels, and contaminant screening—to ensure consistency, prevent spoilage, and meet labeling requirements. Stricter food safety regulations worldwide have heightened the demand for advanced chemical testing methods like chromatography and spectrometry, enabling precise detection of pesticides, heavy metals, and artificial additives. Additionally, growing consumer interest in clean-label and functional juices has spurred investments in additive monitoring. Technological advances that streamline workflows and lower per-sample costs further support the segment’s growth, making chemical testing indispensable for juice manufacturers seeking quality assurance and market differentiation.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261087115

By product type, the mixed juice segment holds a significant market share in the juice testing market.

Mixed juices hold a significant share in the juice testing market due to their rising popularity among health-conscious consumers seeking diverse nutritional profiles from combined fruit and vegetable blends. The complexity of ingredients in mixed juices necessitates rigorous testing to ensure product safety, accurate labeling, and shelf-life stability, driving demand for advanced testing solutions. Growth is fueled by increasing consumer preference for innovative flavor combinations and functional beverages, especially in urban markets. As clean-label and organic trends gain traction, manufacturers are investing more in quality assurance, further expanding the need for comprehensive juice testing. Future opportunities lie in the development of rapid testing technologies, AI-driven quality analysis, and tailored testing protocols for plant-based nutrient blends. Additionally, regulatory tightening in export markets will encourage producers to enhance testing compliance, making mixed juices a sustained contributor to the expansion of the juice testing market globally.

Asia Pacific is estimated to be the fastest-growing region in the juice testing market.

Asia Pacific is expected to be the fastest-growing region in the fruit juice testing market, driven by rising health awareness, expanding urban populations, and increasing consumption of packaged beverages. Rapid industrialization, coupled with growing regulatory scrutiny on food safety, is pushing manufacturers to adopt stringent quality control measures. Countries such as China, India, Japan, and South Korea are witnessing a surge in demand for both domestic and export-quality juices, fueling the need for comprehensive testing protocols. Moreover, the presence of emerging testing labs, technological advancements, and government initiatives supporting food safety standards are creating favorable conditions for market expansion. As consumer demand for safe, high-quality juice products grows, the region is set to see sustained momentum in juice testing solutions.

Leading Juice Testing Companies:

The report profiles key players such as Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA (Switzerland), ALS (Australia), Intertek Group plc (UK), Mérieux NutriSciences Corporation (France), Certified Group (US), TÜV SÜD (Germany), Symbio Labs (Australia), Alfa Chemistry (US), FoodChain ID (US), AGQ Labs (Spain), Tentamus (Germany), LAUDA DR. R. WOBSER GMBH & CO. KG (Germany), Centre Testing International (China), and Agilent Technologies, Inc. (US).

Recent Developments of Juice Testing Industry:

  1. In February 2025, Intertek launched its regional headquarters in Riyadh, further localizing ATIC services for beverage manufacturers and driving Saudi Arabia’s diversified industrial expansion with quicker compliance and testing solutions.
  2. In February 2025, Mérieux NutriSciences purchased Bureau Veritas’ food testing activities in several regions, expanding the global network of laboratories and reinforcing juice testing with increased infrastructure and regulatory compliance services.
  3. In October 2024, SGS inaugurated a new food and nutraceutical testing laboratory in Fairfield, New Jersey, upgrading its North American juice testing capability and compliance assistance for FSMA regulations.
  4. In August 2024, ALS launched InviRapid Lateral Flow Test Strips for quick on-site detection of allergens, complementing HACCP programs and increasing allergen safety in juice and beverage processing facilities.

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=261087115

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/juice-testing-market-261087115.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Juice Testing Market to Reach $1.28 Billion by 2030: Trends, Growth Drivers, and Key Players

Cell Counting Market to Hit USD 16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™

“The prominent players operating in the cell counting market are Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGAA, and Bio-Rad Laboratories, Inc., among Others.”
Browse 771 market data Tables and 55 Figures spread through 511 Pages and in-depth TOC on “Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) – Global Forecast to 2029

The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in 2024 and an impressive US$16.14 billion by 2029. Advancements in technology, increased research initiatives, and the rising demand for precision diagnostics are key factors driving the global cell counting market. The adoption of automated and digital cell counting solutions, such as fluorescence-based systems, is growing rapidly due to their superior accuracy, efficiency, and integration of artificial intelligence. Furthermore, the expanding biopharmaceutical and biotechnology sectors significantly contribute to this growth, as cell counting is increasingly used in drug discovery, cell therapy, and vaccine development.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728

Browse in-depth TOC on “Cell Counting Market

771 – Tables

55 – Figures

511 – Pages

Based on product, the cell counting market is segmented into consumables and instruments. The consumables segment is further divided into media, sera & reagents, assay kits, microplates, accessories, and other consumables. The instrument segment is further divided into spectrophotometers, flow cytometers, hematology analyzers, cell counters, microscopes, and others. The consumables segment dominated the market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The growing emphasis on personalized medicine, stem cell research, and regenerative therapies has significantly increased the demand for high-quality, application-specific consumables, reinforcing their dominance as the leading product segment in the cell counting market.

The market is segmented by application into research applications, medical applications, and bioproduction and quality control. The research application segment is further divided into cancer research, immunology research, neurology research, stem cell research, and other research applications. The research application dominated the market in 2023 and is anticipated to grow at a significant rate in the coming years. The dominance of the segment is due to increasing R&D investments by pharmaceutical and biotechnology companies for drug discovery and development. Furthermore, the rising focus on cancer research, immunology, and stem cell studies has significantly increased the adoption of cell counting technologies.

The cell counting market is segmented by end users is segmented into academic & research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and CROs & CDMOs. The academic & research institutes dominated the segment owing to various factors such as collaborations between academia and industry for translational research has amplified the demand for cell counting solutions. Rising prevalence of chronic diseases, infectious diseases, and increasing demand for accurate diagnostic solutions impacting the growth of the hospitals & diagnostics laboratories segment.

The cell counting market is segmented by region into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America held dominant share in 2023, and the Asia Pacific region is anticipated grow at significant CAGR during the forecast period of 2024-2029. US dominated the North American cell counting market in 2023 and likely to maintain dominance during the forecasted period. The factors attributable for dominance are the presence of key market players in the country coupled with rising in demand for personalized medicine. Europe held second largest share owing to increased adoption of technologically advanced instruments and to high investment in research and development by biopharmaceutical companies. Furthermore, countries such as Germany, the UK, and France dominate the European cell counting market.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728

The market for cell counting market is competitive, with key players strategizing to capture the majority of market share. Prominent players in the cell counting market are Danaher Corporation (US), Thermo Fisher Scientific (US), Beckton Dickinson and Company (US), and Agilent Technologies Inc. (US), among others. The key market players adopt various organic and inorganic growth strategies, such as investment in technologically advanced products, partnerships, agreements, expansions, and acquisitions to strengthen their position in the cell counting market.

Danaher (US) is one of the leading players in the cell counting market. The company has a presence in more than 60 countries and offers a diversified product portfolio of instruments and consumables in the cell-counting segment. Danaher has a strong focus on organic and inorganic growth strategies to maintain a dominant position in the market. The company operates in the market through Beckmann Coulter, Molecular Devices, SCIEX, Leica Microsystems, and Integrated DNA Technologies among others. Danaher’s robust global distribution network and dedicated customer support help the company to maintain its dominant position in the market.

Thermo Fisher Scientific (US) is one of the dominant players in the cell counting market. The company has a global presence in more than 150 countries and has diversified products for cell counting market. The company’s product offered by the company includes instruments and consumables such as automated cell counter, flow cytometer, microscope, cell imaging systems, and microplate readers. A robust global distribution network and customer-centric approach ensure Thermo Fisher serves diverse sectors, including academia, biotechnology, and pharmaceuticals.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cell-counting-market-157450728.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cell Counting Market to Hit USD 16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™